BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18804696)

  • 1. Exploitation of the folate receptor in the management of cancer and inflammatory disease.
    Leamon CP; Jackman AL
    Vitam Horm; 2008; 79():203-33. PubMed ID: 18804696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-targeted drug strategies for the treatment of cancer.
    Leamon CP
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1277-86. PubMed ID: 19037834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-targeted chemotherapy.
    Leamon CP; Reddy JA
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor detection using folate receptor-targeted imaging agents.
    Sega EI; Low PS
    Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
    Müller C; Schubiger PA; Schibli R
    Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
    Lu Y; Sega E; Leamon CP; Low PS
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1161-76. PubMed ID: 15094213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifolates targeted specifically to the folate receptor.
    Jackman AL; Theti DS; Gibbs DD
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1111-25. PubMed ID: 15094210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The folate receptor as a rational therapeutic target for personalized cancer treatment.
    Assaraf YG; Leamon CP; Reddy JA
    Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates.
    Leamon CP; Reddy JA; Dorton R; Bloomfield A; Emsweller K; Parker N; Westrick E
    J Pharmacol Exp Ther; 2008 Dec; 327(3):918-25. PubMed ID: 18791065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The folate receptor: what does it promise in tissue-targeted therapeutics?
    Salazar MD; Ratnam M
    Cancer Metastasis Rev; 2007 Mar; 26(1):141-52. PubMed ID: 17333345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
    Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
    Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-selective drug delivery via folate receptor-targeted liposomes.
    Pan X; Lee RJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):7-17. PubMed ID: 16296717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate receptor-targeted drugs for cancer and inflammatory diseases.
    Low PS; Antony AC
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1055-8. PubMed ID: 15094205
    [No Abstract]   [Full Text] [Related]  

  • 17. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
    Reddy JA; Westrick E; Santhapuram HK; Howard SJ; Miller ML; Vetzel M; Vlahov I; Chari RV; Goldmacher VS; Leamon CP
    Cancer Res; 2007 Jul; 67(13):6376-82. PubMed ID: 17616697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.
    Reddy JA; Westrick E; Vlahov I; Howard SJ; Santhapuram HK; Leamon CP
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):229-36. PubMed ID: 16331500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-linked drugs for the treatment of cancer and inflammatory diseases.
    Yang J; Vlashi E; Low P
    Subcell Biochem; 2012; 56():163-79. PubMed ID: 22116699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.